These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37243204)

  • 1. GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage.
    Ha DP; Shin WJ; Hernandez JC; Neamati N; Dubeau L; Machida K; Lee AS
    Viruses; 2023 May; 15(5):. PubMed ID: 37243204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
    Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
    J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors.
    Yamamoto V; Ha DP; Liu Z; Huang M; Samanta S; Neamati N; Lee AS
    Neoplasia; 2024 Sep; 55():101020. PubMed ID: 38991376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer.
    Samanta S; Yang S; Debnath B; Xue D; Kuang Y; Ramkumar K; Lee AS; Ljungman M; Neamati N
    Cancer Res; 2021 Apr; 81(7):1883-1895. PubMed ID: 33531374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE2-independent SARS-CoV-2 virus entry through cell surface GRP78 on monocytes - evidence from a translational clinical and experimental approach.
    Han B; Lv Y; Moser D; Zhou X; Woehrle T; Han L; Osterman A; Rudelius M; Choukér A; Lei P
    EBioMedicine; 2023 Dec; 98():104869. PubMed ID: 37967509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure.
    Murthy A; Rodriguez LR; Dimopoulos T; Bui S; Iyer S; Chavez K; Tomer Y; Abraham V; Cooper C; Renner DM; Katzen JB; Bentley ID; Ghadiali SN; Englert JA; Weiss SR; Beers MF
    Am J Physiol Lung Cell Mol Physiol; 2024 Aug; 327(2):L232-L249. PubMed ID: 38860845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.
    Lazou M; Hutton JR; Chakravarty A; Joseph-McCarthy D
    J Comput Aided Mol Des; 2024 Jan; 38(1):6. PubMed ID: 38263499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19.
    Shin J; Toyoda S; Nishitani S; Fukuhara A; Kita S; Otsuki M; Shimomura I
    Diabetes; 2021 Dec; 70(12):2745-2755. PubMed ID: 34615619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.
    Rayner JO; Roberts RA; Kim J; Poklepovic A; Roberts JL; Booth L; Dent P
    Biochem Pharmacol; 2020 Dec; 182():114227. PubMed ID: 32966814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Spike Protein-Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78.
    Johnson N; Pattinson C; Burgoyne K; Hijazi K; Houssen WE; Milne BF
    Chembiochem; 2024 Jun; 25(12):e202300789. PubMed ID: 38613462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression and
    Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.
    Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S
    mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of head and neck cancer cell survival and cisplatin resistance by GRP78 small molecule inhibitor YUM70.
    Yamamoto V; Wang B; Lee AS
    Front Oncol; 2022; 12():1044699. PubMed ID: 36713577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies.
    Puzyrenko A; Jacobs ER; Sun Y; Felix JC; Sheinin Y; Ge L; Lai S; Dai Q; Gantner BN; Nanchal R; North PE; Simpson PM; Rui H; Benjamin IJ
    Cell Stress Chaperones; 2021 Sep; 26(5):859-868. PubMed ID: 34382151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.
    Wang WJ; Chen Y; Su WC; Liu YY; Shen WJ; Chang WC; Huang ST; Lin CW; Wang YC; Yang CS; Hou MH; Chou YC; Wu YC; Wang SC; Hung MC
    J Food Biochem; 2022 Oct; 46(10):e14354. PubMed ID: 35894128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.
    Fernandez RA; Quimque MT; Notarte KI; Manzano JA; Pilapil DY; de Leon VN; San Jose JJ; Villalobos O; Muralidharan NH; Gromiha MM; Brogi S; Macabeo APG
    J Biomol Struct Dyn; 2022; 40(22):12209-12220. PubMed ID: 34463219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.